GlaxoSmithKline plc (the 'Company')
Transaction notification
1. |
Details of PDMR/person closely associated with them ('PCA') |
|||||||
a) |
Name |
Mr D S Redfern |
||||||
b) |
Position/status |
Chief Strategy Officer |
||||||
c) |
Initial notification/ amendment |
Initial notification |
||||||
2. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
GlaxoSmithKline plc |
||||||
b) |
LEI |
5493000HZTVUYLO1D793 |
||||||
3. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted |
|||||||
a) |
Description of the financial instrument |
Ordinary shares of 25 pence each ISIN: GB0009252882
|
||||||
b) |
Nature of the transaction |
Acquisition of ordinary shares under the Company's ShareReward Plan
|
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information
Aggregated volume Price |
14 Ordinary shares £16.7127
|
||||||
e) |
Date of the transaction |
2016-07-11 (12:18 GMT) |
||||||
f) |
Place of the transaction
|
London Stock Exchange (XLON) |